Drug Shortage Report for LIDOCAINE HYDROCHLORIDE INJECTION USP

Last updated on 2025-03-11 History
Report ID 250245
Drug Identification Number 00436208
Brand name LIDOCAINE HYDROCHLORIDE INJECTION USP
Common or Proper name LIDOCAINE HYDROCHLORIDE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LIDOCAINE HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10x 5mL LifeShield
ATC code C01BB
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-02-11
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2025-03-11
Company comments Ansyr Presentation fully available
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2025-03-11 French Compare
v3 2025-03-11 English Compare
v2 2025-02-12 French Compare
v1 2025-02-12 English Compare

Showing 1 to 4 of 4